Accolade and Headspace Health to increase access to preventative resources and mental health services for adolescents and teens amid national mental health crisis SEATTLE , May 10, 2022 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company that provides millions of individuals and their families

SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com. Thursday, May 12 at 1pm ET .

Medication Integrated Care combines pharmacist-led medication therapy management with advanced analytics powered by Rx Savings Solutions to help employers reach individuals most likely to struggle with prescription complications and barriers to care. SEATTLE , May 3, 2022 /PRNewswire/ -- Accolade

Accolade welcomes executive vice president and chief human resources officer Jennifer Hanson to create an amazing employee experience for the company that partners with human resource leaders to deliver Personalized Healthcare SEATTLE , May 2, 2022 /PRNewswire/ -- Accolade, Inc.  (Nasdaq: ACCD),

Fiscal fourth quarter 2022 revenue of $93.8 million, a 58% increase compared to fiscal fourth quarter 2021 revenue of $59.2 million Fiscal year 2022 revenue of $310.0 million, an 82% increase compared to fiscal year 2021 revenue of $170.4 million SEATTLE, April 28, 2022 (GLOBE NEWSWIRE) --

SEATTLE, April 14, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, today announced that it will release fiscal fourth quarter and full year 2022 financial results on Thursday, April 28, 2022, after the market

New third-party research demonstrates how Accolade enhances employee retention and recruitment, overall experience and satisfaction, and perception of health insurance provider. SEATTLE , March 22, 2022 /PRNewswire/ --  Accolade (Nasdaq: ACCD), the company that provides millions of individuals and

SEATTLE, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, will participate in the 2022 SVB Leerink Global Healthcare Conference, including a fireside chat presentation on Friday, February 18, 2022 at 2:20

SEATTLE, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, will participate in 24th Annual Needham Growth Conference, including a presentation on Friday, January 14, 2022 at 12:30 p.m. E.T.

Fiscal third quarter 2022 revenue of $83.5 million, a 117% increase compared to fiscal third quarter 2021 revenue of $38.4 million  Company introduces preliminary guidance for fiscal year 2023, expecting 25% growth in revenue and a reduction in Adjusted EBITDA loss Initial Accolade One and Accolade